1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.

MLA

Piccolo, Raffaele, et al. “1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.” Journal of the American College of Cardiology, vol. 68, no. 7, Aug. 2016, pp. 727–38. EBSCOhost, https://doi.org/10.1016/j.jacc.2016.05.078.

APA

Piccolo, R., Eitel, I., Galasso, G., Dominguez-Rodriguez, A., Iversen, A. Z., Abreu-Gonzalez, P., Windecker, S., Thiele, H., & Piscione, F. (2016). 1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention. Journal of the American College of Cardiology, 68(7), 727–738. https://doi.org/10.1016/j.jacc.2016.05.078

Chicago

Piccolo, Raffaele, Ingo Eitel, Gennaro Galasso, Alberto Dominguez-Rodriguez, Allan Zeeberg Iversen, Pedro Abreu-Gonzalez, Stephan Windecker, Holger Thiele, and Federico Piscione. 2016. “1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.” Journal of the American College of Cardiology 68 (7): 727–38. doi:10.1016/j.jacc.2016.05.078.